×

Extended-release topiramate capsules

  • US 10,172,878 B2
  • Filed: 11/21/2016
  • Issued: 01/08/2019
  • Est. Priority Date: 03/15/2013
  • Status: Active Grant
First Claim
Patent Images

1. A container comprising an extended-release topiramate capsule and desiccant, wherein the extended-release topiramate capsule comprises:

  • a capsule shell comprising a single population of coated particles;

    wherein each coated particle comprises a core and a coating thereon;

    wherein each particle core comprises a homogeneous mixture throughout its core, the mixture comprising;

    topiramate;

    one or more filler(s); and

    one or more binder(s);

    wherein the coating comprises;

    one or more release controlling agent(s);

    one or more pore former(s); and

    one or more plasticizer(s);

    wherein the components in the particle core and coating are present in amounts that provide extended release of topiramate; and

    wherein, when a single dose is given to a healthy human subject, an AUC0-inf of 170 to 210 h·

    μ

    g/mL within a 95% confidence interval, and a Cmax of 2 to 4 μ

    g/mL within a 95% confidence interval are achieved in the subject'"'"'s plasma.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×